Hisashi Takeuchi Selected Research

M-VAC protocol

8/2011

The efficacy and safety of gemcitabine plus cisplatin regimen for patients with advanced urothelial carcinoma after failure of M-VAC regimen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hisashi Takeuchi Research Topics

Disease

4	Prostatic Neoplasms (Prostate Cancer) 03/2020 - 12/2010
4	Neoplasms (Cancer) 03/2020 - 07/2008
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016 - 10/2014
2	Neoplasm Metastasis (Metastasis) 04/2018 - 08/2011
2	Carcinoma (Carcinomatosis) 08/2011 - 03/2009
1	Hypogonadism (Hypergonadotropic Hypogonadism) 10/2021
1	Urolithiasis 07/2019
1	Calculi (Calculus) 07/2019
1	Disease Progression 04/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2018
1	Surgical Wound Infection 10/2014
1	Diabetes Mellitus 10/2014
1	Margins of Excision 09/2013
1	Gastritis 07/2013
1	Stomach Neoplasms (Stomach Cancer) 07/2013
1	Proctitis 01/2012
1	Pelvic Neoplasms 01/2012
1	Hemorrhage 03/2011
1	Carcinogenesis 07/2008

Drug/Important Bio-Agent (IBA)

2	Prostate-Specific Antigen (Semenogelase)IBA 02/2017 - 09/2013
2	Gemcitabine FDA Link 11/2015 - 08/2011
2	Hemoglobins (Hemoglobin)IBA 08/2011 - 03/2011
1	Phosphodiesterase 5 InhibitorsIBA 10/2021
1	Testosterone (Sustanon)FDA Link 10/2021
1	Uric Acid (Urate)IBA 07/2019
1	Sorafenib (BAY 43-9006)FDA Link 04/2018
1	A 19IBA 04/2018
1	pazopanib FDA Link 04/2018
1	A 7 (A-7)IBA 04/2018
1	AntioxidantsIBA 01/2016
1	thiazolyl blueIBA 01/2016
1	methyl 2- cyano- 3,11- dioxo- 18beta- olean- 1,12- dien- 30- oateIBA 01/2016
1	Antineoplastic Agents (Antineoplastics)IBA 01/2016
1	Glutathione (Reduced Glutathione)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	Sp Transcription FactorsIBA 01/2016
1	Estrogen ReceptorsIBA 11/2015
1	Tamoxifen FDA LinkGeneric 11/2015
1	4-toluenesulfonyl fluoride (TSF)IBA 10/2014
1	AntralIBA 07/2013
1	Messenger RNA (mRNA)IBA 01/2012
1	angiogeninIBA 01/2012
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2012
1	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2012
1	EndoglinIBA 01/2012
1	Matrix Metalloproteinases (MMPs)IBA 01/2012
1	SERPIN-B5 (maspin)IBA 01/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2011
1	Cisplatin (Platino)FDA LinkGeneric 08/2011
1	Methotrexate (Mexate)FDA LinkGeneric 08/2011

Therapy/Procedure

3	Conservative Treatment 03/2020 - 12/2010
2	Therapeutics 10/2021 - 12/2010
2	Nephrectomy 04/2018 - 03/2009
2	Prostatectomy (Retropubic Prostatectomy) 02/2017 - 09/2013
2	Drug Therapy (Chemotherapy) 11/2015 - 08/2011
1	Kampo Medicine (Kampo) 10/2021
1	Diet Therapy (Therapy, Diet) 07/2019
1	Molecular Targeted Therapy 04/2018
1	Urinary Diversion (Ileal Conduit) 10/2014
1	Cystectomy 10/2014
1	Radiotherapy 01/2012
1	Combination Drug Therapy (Combination Chemotherapy) 08/2011
1	M-VAC protocol 08/2011
1	Brachytherapy 12/2010
1	Chemoprevention 07/2008